Overview
Listen to the thought leaders in Pulmonology and Respiratory Medicine on how to manage Asthma in COVID-Era in the light of new GINA 2021 update, and whether it is high time to side step from Blue Inhalers (SABAs).
Faculty
Dr. A. G. Ghoshal
MD, DNB, FCCP, FICA, Fellow ICS, Ex WHO Fellow
Medical Director | National Allergy Asthma Bronchitis Institute | Consultant Pulmonologist & BronchoscopistKolkata
Dr Raja Dhar
MBBS (Cal), MD (Respiratory Medicine), MRCP (UK) MSc (Evidence Based Medicine, UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University) Certificate in Education (Deeside University)Director & HoD Pulmonology, Fortis Hospital. Director, Research & Education, National Allergy Asthma Bronchitis Institute, Kolkata, India
Dr. R Vijai Kumar
MD, DTCD, MBBS, FAARC (USA), FCCP (USA)Pulmonologist, Pulmonary & Critical Care, Hyderabad, Telangana, India
Dr Amita Nene
MD, DETRD, FCCP (USA)Head, Dept of Respiratory Medicine, Bombay Hospital, Mumbai, Maharashtra, India
Dr. Indranil Halder
DCH(Cal), MD(Cal), FCCP (USA), FICP, European Diploma in adult Respiratory MedicineMD (Pulmonary Medicine), DCH,FCCP (USA), FICP | Consultant Pulmonologist, Associate Professor & HOD, Pulmonary Medicine in College of Medicine and JNM Hospital, West Bengal.Resources
External Resources
Asthma Management in the COVID-Era
Also Read
Our Research
Our Research
